Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303). - Schwebke, Jane R; Sobel, Ryan; Gersten, Janet K; Sussman, Steven A; Lederman, Samuel N; Jacobs, Mark A; Chappell, B Todd; Weinstein, David L; Moffett, Alfred H; Azie, Nkechi E; Angulo, David A; Harriott, Itzel A; et al. (Clinical Infectious Diseases, 2022)